Oculis Holding GAAP EPS of CHF -0.42 beats by $0.11
Source: SeekingAlpha
2026-03-03 16:59:12 ET
More on Oculis Holding
- Oculis Holding AG (OCS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Oculis Holding AG (OCS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Oculis gains on FDA breakthrough therapy status for optic neuritis therapy
- Seeking Alpha’s Quant Rating on Oculis Holding
- Historical earnings data for Oculis Holding
Read the full article on Seeking Alpha
For further details see:
Oculis Holding GAAP EPS of CHF -0.42 beats by $0.11
Oculis Holding AG
NASDAQ: OCS
OCS Trading
-4.07% G/L:
$26.90 Last:
190,365 Volume:
$27.73 Open:
OCS Latest News
March 03, 2026 04:05:00 pm
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
OCS Stock Data
$1,527,387,432
49,696,926
N/A
16
N/A
Biotechnology & Life Sciences
Healthcare
CH
